Clinical and operative characteristics of patients who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
| Characteristic | No. (%) of patients* |
|---|---|
| Procedure | |
| Splenectomy | 31 (22.0) |
| Hepatic resection | 33 (23.4) |
| Peritonectomy | 120 (85.1) |
| Right diaphragm resection | 62 (43.9) |
| Left diaphragm resection | 32 (22.6) |
| Glisson capsulectomy | 44 (31.2) |
| Cholecystectomy | 14 (9.9) |
| Partial gastrectomy | 9 (6.3) |
| Lesser omentum resection | 11 (7.8) |
| Partial pancreatectomy | 7 (4.9) |
| Small bowel resection | 61 (43.2) |
| Right hemicolectomy | 53 (37.5) |
| Left hemicolectomy | 42 (29.7) |
| Resection of rectum | 21 (14.8) |
| Hysterectomy in females | 32/83 (38.5) |
| BSO in females | 47/83 (56.6) |
| Partial cystectomy | 5 (3.5) |
| Bowel anastomosis | 75 (53) |
| No. of bowel anastomoses per patient, mean (range) | 1 (0–3) |
| Anastomosis leak | 2 |
| Duration of surgery, h, mean (range) | 8.9 (2.5–17.5) |
| Blood loss, mL, mean (range) | 548 (15–3000) |
| Blood transfusion | 36 (25.5) |
| Duration of ICU stay, d, mean (range) | 1.5 (0–33) |
| Duration of hospital admission, d, mean (range) | 16.75 (5–184) |
| CCI score, mean (range) | 17.7 (8–50.1) |
| PCI score, mean (range) | 15 (1–39) |
| Completeness of cytoreduction | |
| CC-0 | 89 |
| CC-1 | 28 |
| CC-2 | 7 |
| Unspecified | 16 |
BSO = bilateral salpingo-oophorectomy; CC-0 = no macroscopic residual cancer remained; CC-1 = no nodule > 2.5 mm in diameter remained; CC-2 = nodules between 2.5 mm and 2.5 cm in diameter remained; CCI = Comprehensive Complication Index; ICU = intensive care unit; PCI = peritoneal cancer index.
↵* Unless indicated otherwise.